๐ Feasibility and Dosimetric Outcomes of CT-Based Daily Adaptive SABR in Patients Receiving Salvage Treatment for Biochemical Recurrence of Prostate Cancer
๐
advancesradonc.org/article/Sโฆ
โข๏ธSingle-center phase II DAPPER study: 50 patients with biochemical recurrence after prostatectomy received CT-based daily adaptive SABR to the prostate fossa ยฑ pelvic nodes (5 fx).
๐ Feasibility: 98% of fractions (246/250).
๐ Plan selection: Adaptive plans selected in 89% of fractions.
๐ Dosimetric outcomes: Improved target coverage and reduce bowel and rectal V25Gy.
@ASTRO_org @DrStish @WaddleMd @EricLehrer @RomanKowalchuk @MayoRadOnc